How can human DAF and HRF20 prevent HAR in transgenic mice?
Koike
C
C
Department of Surgery II, Nagoya University School of Medicine, Japan.
Isobe
K
K
Nakashima
I
I
Okada
H
H
Hayashi
S
S
Yokoyama
I
I
Takagi
H
H
D000017:ABO Blood-Group System / Q000276:immunology; D000328:Adult; D000818:Animals; D015139:Blotting, Southern; D018958:CD55 Antigens / Q000096:biosynthesis / Q000276:immunology*; D018957:CD59 Antigens / Q000096:biosynthesis / Q000276:immunology*; D003165:Complement System Proteins / Q000276:immunology; D006084:Graft Rejection / Q000276:immunology / Q000517:prevention & control*; D006801:Humans; D051379:Mice; D008822:Mice, Transgenic; D016133:Polymerase Chain Reaction; D011994:Recombinant Proteins / Q000096:biosynthesis / Q000276:immunology; D014183:Transplantation, Heterologous / Q000276:immunology*
D000017:ABO Blood-Group System; D018958:CD55 Antigens; D018957:CD59 Antigens; D011994:Recombinant Proteins; D003165:Complement System Proteins